---
title: "Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293191603.md"
description: "Cantor Fitzgerald analyst Li Watsek maintained a Buy rating on Adlai Nortye Ltd. Sponsored ADR (ANL) on July 16, with shares closing at $11.35. The stock holds a Strong Buy consensus among analysts, featuring a price target of $25.50, implying a 124.67% upside. Additionally, H.C. Wainwright reiterated a Buy rating on July 16 with a $20.00 price target."
datetime: "2026-07-20T09:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293191603.md)
  - [en](https://longbridge.com/en/news/293191603.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293191603.md)
---

# Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Li Watsek maintained a Buy rating on Adlai Nortye Ltd. Sponsored ADR on July 16. The company’s shares closed last Friday at $11.35.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Watsek is an analyst with an average return of \-9.2% and a 39.42% success rate. Watsek covers the Healthcare sector, focusing on stocks such as Adlai Nortye Ltd. Sponsored ADR, Faeth Therapeutics, and Zai Lab.

Adlai Nortye Ltd. Sponsored ADR has an analyst consensus of Strong Buy, with a price target consensus of $25.50, which is a 124.67% upside from current levels. In a report released on July 16, H.C. Wainwright also reiterated a Buy rating on the stock with a $20.00 price target.

### Related Stocks

- [ANL.US](https://longbridge.com/en/quote/ANL.US.md)
- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)
- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)

## Related News & Research

- [Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway](https://longbridge.com/en/news/293951548.md)
- [TD Cowen Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)](https://longbridge.com/en/news/295624079.md)
- [Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/296029142.md)
- [BTIG Keeps Their Buy Rating on Better Home & Finance (BETR)](https://longbridge.com/en/news/295965330.md)
- [Calian Group Ltd. Just Recorded A 137% EPS Beat: Here's What Analysts Are Forecasting Next](https://longbridge.com/en/news/296027740.md)